Legis Daily

Long-Term Care Pharmacy Definition Act of 2020

USA116th CongressHR-7757| House 
| Updated: 7/23/2020
Kurt Schrader

Kurt Schrader

Democratic Representative

Oregon

Cosponsors (3)
Tom O'Halleran (Democratic)Markwayne Mullin (Republican)Earl L. "Buddy" Carter (Republican)

Ways and Means Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Long-Term Care Pharmacy Definition Act of 2020 This bill establishes a statutory definition for long-term care pharmacy under the Medicare prescription drug benefit. Currently, there is no statutory definition. Regulations from the Centers for Medicare & Medicaid Services (CMS) define a long-term care pharmacy as a pharmacy that is owned by or under contract with a long-term care facility to provide prescription drugs to the facility's residents. Additional requirements are set out in CMS guidance relating to the Medicare prescription drug benefit; pharmacies are also subject to regulations and guidance from other agencies (e.g., packaging requirements from the Food and Drug Administration). The bill defines a long-term care pharmacy as a state-licensed pharmacy that is able to provide enhanced pharmacy and clinical services to individuals who have certain comorbid and medically complex chronic conditions and who reside in skilled nursing facilities, nursing facilities, or any other applicable setting (as determined by the CMS). The term enhanced pharmacy and clinical services includes medication dispensed in special packaging, drug utilization review, and 24-7 availability of medication delivery and on-call pharmacists.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 22, 2020

Latest Companion Bill Action

S 116-4259
Introduced in Senate
Jul 23, 2020
Introduced in House
Jul 23, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 22, 2020

    Latest Companion Bill Action

    S 116-4259
    Introduced in Senate


  • July 23, 2020
    Introduced in House


  • July 23, 2020
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Health

Related Bills

  • S 116-4259: Long-Term Care Pharmacy Definition Act of 2020
Health care coverage and accessLong-term, rehabilitative, and terminal careMedicarePrescription drugs

Long-Term Care Pharmacy Definition Act of 2020

USA116th CongressHR-7757| House 
| Updated: 7/23/2020
Long-Term Care Pharmacy Definition Act of 2020 This bill establishes a statutory definition for long-term care pharmacy under the Medicare prescription drug benefit. Currently, there is no statutory definition. Regulations from the Centers for Medicare & Medicaid Services (CMS) define a long-term care pharmacy as a pharmacy that is owned by or under contract with a long-term care facility to provide prescription drugs to the facility's residents. Additional requirements are set out in CMS guidance relating to the Medicare prescription drug benefit; pharmacies are also subject to regulations and guidance from other agencies (e.g., packaging requirements from the Food and Drug Administration). The bill defines a long-term care pharmacy as a state-licensed pharmacy that is able to provide enhanced pharmacy and clinical services to individuals who have certain comorbid and medically complex chronic conditions and who reside in skilled nursing facilities, nursing facilities, or any other applicable setting (as determined by the CMS). The term enhanced pharmacy and clinical services includes medication dispensed in special packaging, drug utilization review, and 24-7 availability of medication delivery and on-call pharmacists.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 22, 2020

Latest Companion Bill Action

S 116-4259
Introduced in Senate
Jul 23, 2020
Introduced in House
Jul 23, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 22, 2020

    Latest Companion Bill Action

    S 116-4259
    Introduced in Senate


  • July 23, 2020
    Introduced in House


  • July 23, 2020
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Kurt Schrader

Kurt Schrader

Democratic Representative

Oregon

Cosponsors (3)
Tom O'Halleran (Democratic)Markwayne Mullin (Republican)Earl L. "Buddy" Carter (Republican)

Ways and Means Committee, Energy and Commerce Committee

Health

Related Bills

  • S 116-4259: Long-Term Care Pharmacy Definition Act of 2020
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health care coverage and accessLong-term, rehabilitative, and terminal careMedicarePrescription drugs